A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsCytopenias
Interventions
DRUG

Filgrastim

Trial Locations (22)

11794

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

20037

George Washington Univ Med Ctr, Washington D.C.

28207

Nalle Clinic, Charlotte

33308

TheraFirst Med Ctrs Inc, Fort Lauderdale

35294

Univ of Alabama at Birmingham / AIDS Outpatient Clinic, Birmingham

44106

Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

78284

Univ TX San Antonio Health Science Ctr, San Antonio

80262

Univ Hosp / Univ of Colorado Health Sci Ctr, Denver

85008

Maricopa County Med Ctr, Phoenix

90095

CARE Ctr / UCLA Med Ctr, Los Angeles

94110

UCSF - San Francisco Gen Hosp, San Francisco

97227

Kaiser Permanente Med Ctr, Portland

672143124

Univ of Kansas School of Medicine, Wichita

701122699

Tulane Univ Med School, New Orleans

02215

New England Deaconess Hosp, Boston

Unknown

Saint Paul's Hosp, Vancouver

Sunnybrook Health Science Ctr, Toronto

Toronto Gen Hosp, Toronto

Wellesley Hosp, Toronto

Hotel - Dieu de Montreal, Montreal

Saint Michael's Hosp, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY